⌘K

Home/Filings/4/0001493152-21-006291

4//SEC Filing

Amman Bradford K. 4

Accession 0001493152-21-006291

CIK 0001716166other

View on SEC.gov Company Profile

Filed

Mar 16, 8:00 PM ET

Accepted

Mar 17, 8:48 PM ET

Size

6.1 KB

Accession

0001493152-21-006291

Insider Transaction Report

Form 4

Period: 2021-03-12

Vivos Therapeutics, Inc.VVOS

Amman Bradford K.

Chief Financial Officer

Transactions

Award
Stock Option
2021-03-12$7.50/sh+100,000$750,000→ 200,001 total
Exercise: $7.50Exp: 2026-03-12→ Common Stock (100,000 underlying)

Holdings

Common Stock
1,000

Footnotes (1)

[F1]100,000 stock options granted on March 12, 2021. One-fifth vested immediately and one-fifth vests annually on each anniversary date through March 12, 2025.

Documents

1 file

4
ownership.xmlPrimary

Issuer

Vivos Therapeutics, Inc.

CIK 0001716166

Entity typeother

Related Parties

1

filerCIK 0001425339

Filing Metadata

Form type: 4
Filed: Mar 16, 8:00 PM ET
Accepted: Mar 17, 8:48 PM ET
Size: 6.1 KB

View on SEC.gov